What Is a Patient-Specific Virtual Heart? Connecting ECG, Imaging, Clinical Data, and Computational Modeling

A patient-specific Virtual Heart is a computational representation that brings together information about an individual patient’s cardiovascular state over time. Rather than viewing ECGs, cardiac imaging, laboratory results, medications, clinical history, and physiological measurements as separate records, the goal is to connect these sources into a coherent, longitudinal representation that can be evaluated alongside computational models. xBxBio is developing this approach as part of its research-stage Connected Cardiovascular Intelligence platform to support clinician-guided assessment, comparison, monitoring, and future patient-specific decision support while preserving clinical context, provenance, uncertainty, and human oversight.

What Makes a Virtual Heart Patient-Specific?

A Virtual Heart becomes patient-specific when its anatomical, electrical, mechanical, hemodynamic, and clinical characteristics are informed by evidence from a particular patient rather than by a generic cardiovascular model alone. Relevant information may include ECG and rhythm data, echocardiography, CT or MRI, laboratory measurements, medications, diagnoses, procedures, physiological observations, and other longitudinal clinical information.

Patient specificity also requires the model to change as the patient changes. New imaging studies, ECGs, laboratory results, medication changes, procedures, and clinical events can provide additional evidence for updating the representation over time. This longitudinal approach allows comparison of earlier and later states, examination of differences between predicted and observed findings, and maintenance of a traceable record of the evidence supporting each model state.

How Multimodal Cardiovascular Data Fits Together

A patient-specific Virtual Heart depends on more than one type of cardiovascular evidence. ECG and rhythm data can provide information about electrical activity, while echocardiography, CT, MRI, and other imaging modalities can provide anatomical and functional information. Laboratory results, medications, diagnoses, procedures, physiological measurements, and longitudinal clinical events add further context about the patient’s evolving cardiovascular state.

The value comes from connecting these sources rather than treating them as isolated records. When multimodal information is aligned by patient identity and time, clinicians and researchers can examine how electrical, structural, mechanical, hemodynamic, and clinical findings relate to one another. This also preserves the provenance of each observation, tracks changes over time, and identifies where evidence agrees, conflicts, or remains uncertain.

Where Computational Modeling Adds Value

Computational modeling connects observed patient data with mathematical representations of cardiovascular physiology. Depending on the question being studied, models may represent cardiac electrical activation, myocardial mechanics, blood flow, chamber pressures, vascular loading, or interactions among these processes. The purpose is not to replace measured clinical data, but to provide a framework for interpreting that data and exploring how different physiological factors may relate to one another.

n a patient-specific setting, model parameters can be informed or constrained by available evidence from the individual patient. Predictions can then be compared with observed findings, allowing discrepancies, uncertainty, and model limitations to be identified explicitly. This comparison between prediction and observation is essential for keeping a Virtual Heart evidence-aware rather than treating simulation output as established clinical fact.

Why Longitudinal Updating Matters

A patient-specific cardiovascular representation should not remain static. New ECGs, imaging studies, laboratory results, medication changes, procedures, symptoms, and other clinical events can alter what is known about the patient. Updating the Virtual Heart over time allows the representation to reflect the most current evidence while preserving earlier states for comparison.

This longitudinal structure can support trend analysis, reconstruction of prior patient states, and comparison between predicted and observed outcomes. It also creates a clearer record of how the model evolved, what evidence informed each update, and which assumptions or uncertainties changed over time.

Interoperability, Provenance, and Data Integrity

A patient-specific Virtual Heart depends on reliable information exchange across multiple clinical systems and data types. Standards such as HL7 FHIR and DICOM can support the exchange of structured clinical data and medical imaging, while cardiovascular information systems, PACS, ECG platforms, laboratory systems, and electronic health records each contribute to the patient’s longitudinal record.

Integration alone is not enough. Each data element should retain its source, timestamp, version, and relevant clinical context so that users can understand where the information came from and how it was used. Preserving provenance, traceability, and version history is essential for distinguishing observed evidence from derived values, model assumptions, and simulation results.

Uncertainty, Validation, and Human Oversight

Patient-specific modeling inevitably involves uncertainty. Clinical measurements may be incomplete, acquired at different times, generated by different devices, or affected by measurement variability. Computational models also depend on assumptions, parameter choices, boundary conditions, and simplifications. A credible Virtual Heart framework therefore needs to make uncertainty visible rather than presenting every output as equally certain.

Validation requires comparing model behavior with observed clinical evidence and documenting where the model performs well, where discrepancies remain, and what additional evidence may be needed. Human oversight is equally important: computational outputs should support expert interpretation and clinician-guided assessment rather than replace professional judgment.

How xBxBio Has Developed the Virtual Heart

xBxBio has developed its Virtual Heart as part of a broader Connected Cardiovascular Intelligence framework that connects longitudinal clinical evidence with patient-specific computational modeling.The approach brings together information such as ECG, cardiac imaging, laboratory results, medications, clinical history, physiological measurements, and other cardiovascular data while maintaining traceability to the underlying evidence.

The xBxBio Virtual Heart remains a research-stage, pre-commercial development program. Its purpose is to investigate how patient-specific cardiovascular representations, physiological simulation, longitudinal updating, uncertainty analysis, and multimodal evidence integration could support future clinician-guided assessment and decision support. It is not currently presented as a substitute for clinical judgment, an approved medical device, or a system for independently diagnosing or treating patients.

What This Could Mean for Cardiovascular Care

If patient-specific cardiovascular models can be developed and validated with sufficient scientific and clinical rigor, they could help clinicians and researchers examine complex relationships that are difficult to understand from isolated data sources alone. A longitudinal Virtual Heart could potentially support comparison of prior and current patient states, investigation of physiological mechanisms, evaluation of competing hypotheses, and more individualized interpretation of cardiovascular evidence.

The long-term value would come from combining computational insight with high-quality clinical evidence, transparent uncertainty, interoperability, and expert oversight. For xBxBio, the objective is not simply to create another visualization of the heart, but to investigate whether a continuously updated, evidence-linked cardiovascular representation can become a useful component of future patient-specific assessment, monitoring, and clinician-guided decision support.

Looking Ahead

Building a patient-specific Virtual Heart requires more than a single model or data source. It requires coordinated advances in multimodal data integration, computational physiology, interoperability, validation, uncertainty quantification, provenance, longitudinal updating, and clinical governance. Each of these elements must work together if a digital representation of the heart is to remain scientifically meaningful as new patient evidence becomes available.

xBxBio’s ongoing research focuses on developing and evaluating this connected framework while clearly separating observed clinical evidence from computational inference and experimental prediction. As the platform and Virtual Heart mature, xBxBio intends to continue documenting the scientific methods, limitations, validation approach, and supporting evidence behind the work.

Learn More About xBxBio

xBxBio is continuing to develop its Connected Cardiovascular Intelligence platform and patient-specific Virtual Heart research framework. Readers can explore xBxBio’s public research materials, scientific white papers, and ongoing development updates through the xBxBio website and its public evidence resources.

Research-stage notice: xBxBio and the xBxBio Virtual Heart are research-stage, pre-commercial technologies under development. They are not currently approved medical devices and are not intended to independently diagnose, treat, cure, or prevent disease or to replace qualified clinical judgment.